Literature DB >> 15701649

c-FLIPR, a new regulator of death receptor-induced apoptosis.

Alexander Golks1, Dirk Brenner, Cornelius Fritsch, Peter H Krammer, Inna N Lavrik.   

Abstract

c-FLIPs (c-FLICE inhibitory proteins) play an essential role in regulation of death receptor-induced apoptosis. Multiple splice variants of c-FLIP have been described on the mRNA level; so far only two of them, c-FLIP(L) and c-FLIP(S,) had been found to be expressed at the protein level. In this report, we reveal the endogenous expression of a third isoform of c-FLIP. We demonstrate its presence in a number of T and B cell lines as well as in primary human T cells. We identified this isoform as c-FLIP(R), a death effector domain-only splice variant previously identified on the mRNA level. Impor-/tantly, c-FLIP(R) is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex upon CD95 stimulation. Several properties of c-FLIP(R) are similar to c-FLIP(S): both isoforms have a short half-life, a similar pattern of expression during activation of primary human T cells, and are strongly induced in T cells upon CD3/CD28 costimulation. Taken together, our data demonstrate endogenous expression of c-FLIP(R) and similar roles of c-FLIP(R) and c-FLIP(S) isoforms in death receptor-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701649     DOI: 10.1074/jbc.M414425200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  Regulation of CD95/Fas signaling at the DISC.

Authors:  I N Lavrik; P H Krammer
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  c-FLIP protects T lymphocytes from apoptosis in the intrinsic pathway.

Authors:  Ming-Xiao He; You-Wen He
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 3.  Caspases: pharmacological manipulation of cell death.

Authors:  Inna N Lavrik; Alexander Golks; Peter H Krammer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  S-Adenosylmethionine and methylthioadenosine inhibit cellular FLICE inhibitory protein expression and induce apoptosis in colon cancer cells.

Authors:  Tony W H Li; Qingsong Zhang; Pilsoo Oh; Meng Xia; Hui Chen; Sean Bemanian; Natalie Lastra; Magda Circ; Mary Pat Moyer; José M Mato; Tak Yee Aw; Shelly C Lu
Journal:  Mol Pharmacol       Date:  2009-04-16       Impact factor: 4.436

Review 5.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

6.  Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.

Authors:  Dirk Brenner; Alexander Golks; Friedemann Kiefer; Peter H Krammer; Rüdiger Arnold
Journal:  EMBO J       Date:  2005-12-08       Impact factor: 11.598

Review 7.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

8.  Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis.

Authors:  Hannu T Toivonen; Annika Meinander; Tomoko Asaoka; Mia Westerlund; Frank Pettersson; Andrey Mikhailov; John E Eriksson; Henrik Saxén
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

9.  A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis.

Authors:  Manikuntala Kundu; Sushil Kumar Pathak; Kuldeep Kumawat; Sanchita Basu; Gargi Chatterjee; Shresh Pathak; Takuya Noguchi; Kohsuke Takeda; Hidenori Ichijo; Christine B F Thien; Wallace Y Langdon; Joyoti Basu
Journal:  Nat Immunol       Date:  2009-07-13       Impact factor: 25.606

Review 10.  Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Authors:  Ahmad R Safa; Travis W Day; Ching-Huang Wu
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.